Effect of Formal Letter of Invitation on Male Partner Involvement at Antenatal Care Clinic
Effect Of Letter Of Invitation Through Mother Support Group Counselling To Enhance Male Involvement In Prevention Of Mother To Child Transmission Of HIV Program In Bale Zone, South East Ethiopia: Quasi Experimental Study
1 other identifier
interventional
400
1 country
1
Brief Summary
Prevention of mother to child transmission (PMTCT) of human immune deficiency virus (HIV) program requires great male participation in achieving a sustained reduction of mother-to-child transmission of HIV. Many strategies have been employed to promote male participation in antenatal care but few have been assessed to convey important lessons for scale-up. In Ethiopia, though there is no evidence on its effectiveness, letter of invitation has been tried as a means to promote participation of men in PMTCT program at antenatal care. The study is carried out in two public hospitals to evaluate the effect of letter of invitation delivered through mother support group counselling on male involvement at antenatal care clinic. The findings of this study will directly benefit pregnant women attending antenatal clinic in utilizing PMTCT service effectively. The formal letter of invitation proposed may be incorporated by health service provider in their routine antenatal clinic. It will also help the policy makers to give greater priority to reach and involve men, and to develop effective policies as well as programs to overcome the challenges. Thus, an increase in the uptake of PMTCT services will ultimately lead to a reduction in pediatrics HIV infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
December 6, 2023
CompletedFirst Posted
Study publicly available on registry
December 14, 2023
CompletedDecember 20, 2023
December 1, 2023
6 months
December 6, 2023
December 14, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
To determine male partner accompany at subsequent antenatal care visit
proportion of pregnant women that are accompanied by their partners at week2 and week 8 in the intervention and comparison group
2 to 8 weeks
To determine male partner HIV testing and counseling
proportion of male partners taking up of HIV testing and counselling in both intervention and comparison groups at week 2 and week 8 based on the new WHO ANC model
2 to 8 weeks
Study Arms (2)
intervention group
EXPERIMENTALparticipants on intervention group will receive letter of invitation to invite her partner to attend antenatal care clinic on subsequent visit 2 to 8 weeks
comparison group
NO INTERVENTIONparticipant on comparison group do not receive a letter but will receive routine care to attend antenatal care along with her partner on subsequent visit 2 to 8 weeks
Interventions
A non randomized control trial for the total of six month duration will be employed: the first phase is base line survey (pretest) to determine the magnitude of MI and qualitative method using FGD, IDI and KI with selected group to complement the base line will be conducted. Phase 2 Simultaneously with base line, the intervention will be employed to evaluate the effectiveness of invitation letter through mother support group to pregnant women attending antenatal clinic with out her partner as a strategy for male involvement in PMTCT/ANC services. End line data using qualitative approaches will be collected from partners attending antenatal care clinic following letter of invitation to evaluate the effectiveness of letter of invitation.
Eligibility Criteria
You may qualify if:
- Confirmed pregnancy
- Pregnant women, until 34 weeks gestation. Gestational period is limited to 34 weeks to allow room for suitable evaluation of the strategy as they report for antenatal care
- Pregnant women aged 18 years or older(49) will be eligible
- Marriage or relationship with a woman visited ANC clinic during the study period.
- Pregnant women must be attending antenatal care without a spouse.
- willingness to provide informed consent before study participation
- Planning to attend the antenatal care at the study site on the subsequent visit.
- Permanent residents in intervention and comparison site.
- Partner who is generally accessible (i.e., not permanently working abroad).
- Women should be willing to pass on the invitation letter to their partner whereas in comparison site as she is informed in routine care by antenatal care service provider
- Women has to be normal and expected to follow basic antenatal care
You may not qualify if:
- Partner away from his permanent residents' area during data collections period
- Critical ill husband
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jimma Universitylead
Study Sites (1)
Goba genera hospital
Goba, Oromiya, 302, Ethiopia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecture at Madda Walabu University (MPH in RH)
Study Record Dates
First Submitted
December 6, 2023
First Posted
December 14, 2023
Study Start
June 22, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
December 20, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share